We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+37.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$1.51B
Cap. Flow
+$1.75B
Cap. Flow %
64.98%
Top 10 Hldgs %
35.87%
Holding
269
New
150
Increased
33
Reduced
19
Closed
65

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$80.3M
2
BSX icon
Boston Scientific
BSX
+$76.6M
3
KEY icon
KeyCorp
KEY
+$62.3M
4
GS icon
Goldman Sachs
GS
+$60.3M
5
MMED
MiniMed Group Inc
MMED
+$52.4M

Top Sells

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$40.7M
2
BDX icon
Becton Dickinson
BDX
+$25.5M
3
TPG icon
TPG
TPG
+$23.9M
4
NVO
Novo Nordisk
NVO
+$22.6M
5
EW icon
Edwards Lifesciences
EW
+$22.1M

Sector Composition

Rank Sector Weight
1 Financials 31.18%
2 Healthcare 16.78%
3 Technology 12.09%
4 Industrials 6.84%
5 Consumer Discretionary 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBKR icon
51
Interactive Brokers
IBKR
$40.9B
$15.5M 0.57%
+231,496
New +$16.5M
VRSN icon
52
VeriSign
VRSN
$25.3B
$15.2M 0.56%
61,259
-10,019
-14% -$2.38M
HD icon
53
Home Depot
HD
$332B
$15.1M 0.56%
+46,000
New +$16.8M
KNTK icon
54
Kinetik
KNTK
$3.71B
$15.1M 0.56%
311,000
+224,636
+260% +$9.56M
BTDR icon
55
Bitdeer Technologies
BTDR
$2.81B
$14.7M 0.54%
+1,696,268
New +$17.8M
IEX icon
56
IDEX
IEX
$16.5B
$13.8M 0.51%
+72,952
New +$14.4M
PFE icon
57
CALL
Pfizer
PFE
$140B
$13.5M 0.5%
+480,000
New +$12.8M
AFRM icon
58
Affirm
AFRM
$23.5B
$13.1M 0.48%
+285,099
New +$16.5M
COGT icon
59
Cogent Biosciences
COGT
$6.79B
$12.9M 0.48%
+335,000
New +$12.4M
GWW icon
60
W.W. Grainger
GWW
$65.3B
$12.3M 0.46%
+11,267
New +$12.3M
ARWR icon
61
Arrowhead Research
ARWR
$12.1B
$12.2M 0.45%
+194,589
New +$12.3M
MTD icon
62
Mettler-Toledo International
MTD
$26.8B
$11.7M 0.43%
+9,250
New +$12.5M
BNY
63
Bank of New York Mellon
BNY
$108B
$11.3M 0.42%
+95,176
New +$11.3M
VRTX icon
64
Vertex Pharmaceuticals
VRTX
$121B
$11.1M 0.41%
+24,935
New +$11.6M
STUB
65
CALL
StubHub Holdings
STUB
$3.1B
$10.9M 0.4%
1,750,000
+750,000
+75% +$7.81M
ONON icon
66
On Holding
ONON
$11.9B
$10.6M 0.39%
+313,000
New +$13.7M
BNTX icon
67
BioNTech
BNTX
$22.6B
$10.6M 0.39%
+119,204
New +$12.2M
GLBE icon
68
Global E Online
GLBE
$6.08B
$10.6M 0.39%
342,516
+102,790
+43% +$3.62M
ASB icon
69
Associated Banc-Corp
ASB
$5.81B
$10.5M 0.39%
+405,311
New +$10.8M
ONB icon
70
Old National Bancorp
ONB
$10.1B
$10.3M 0.38%
+464,469
New +$10.8M
AME icon
71
Ametek
AME
$55.5B
$10.2M 0.38%
+47,729
New +$10.6M
BAH icon
72
Booz Allen Hamilton
BAH
$8.7B
$9.63M 0.36%
+123,386
New +$10.4M
AMAT icon
73
CALL
Applied Materials
AMAT
$426B
$9.57M 0.35%
+28,000
New +$9.42M
CTNM
74
Contineum Therapeutics
CTNM
$526M
$9.56M 0.35%
732,088
+262,088
+56% +$3.52M
QGEN icon
75
Qiagen
QGEN
$8.53B
$9.21M 0.34%
+230,000
New +$10.9M

Similar funds

Longaeva Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Longaeva Partners held 269 positions worth $2.7B, up 127% from $1.19B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Longaeva Partners deployed $1.75B of net new capital in Q1 2026, opening 150 new positions and adding to 33 existing holdings. Its largest new stake was Bank of America: 1,555,661 shares worth $75.8M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Annexon, an estimated $14M trimmed.

  • Longaeva Partners's largest Q1 2026 buy was Bank of America: 1,555,661 shares worth $75.8M.
  • Longaeva Partners added most to PNC Financial Services in Q1 2026, an estimated $48M increase.
  • Longaeva Partners's biggest Q1 2026 reduction was Annexon, cutting an estimated $14M.
  • Longaeva Partners fully exited Caris Life Sciences in Q1 2026, selling an estimated $40.7M.
  • Longaeva Partners's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Longaeva Partners opened 150 new positions and closed 65 in Q1 2026.
  • Longaeva Partners's portfolio value rose 127% quarter-over-quarter to $2.7B.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.